BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20454619)

  • 21. In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.
    Niesen J; Brehm H; Stein C; Berges N; Pardo A; Fischer R; Ten Haaf A; Gattenlöhner S; Tur MK; Barth S
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1049-61. PubMed ID: 25433506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis.
    Heinicke U; Kupka J; Fulda S
    Oncotarget; 2015 Nov; 6(35):37836-51. PubMed ID: 26473375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.
    Basak A; Lazure C
    Biochem J; 2003 Jul; 373(Pt 1):231-9. PubMed ID: 12662153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.
    Alcon C; Manzano-Muñoz A; Prada E; Mora J; Soriano A; Guillén G; Gallego S; Roma J; Samitier J; Villanueva A; Montero J
    Cell Death Dis; 2020 Aug; 11(8):634. PubMed ID: 32801295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histidine-rich human salivary peptides are inhibitors of proprotein convertases furin and PC7 but act as substrates for PC1.
    Basak A; Ernst B; Brewer D; Seidah NG; Munzer JS; Lazure C; Lajoie GA
    J Pept Res; 1997 Jun; 49(6):596-603. PubMed ID: 9266488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.
    Olanich ME; Sun W; Hewitt SM; Abdullaev Z; Pack SD; Barr FG
    Clin Cancer Res; 2015 Nov; 21(21):4947-59. PubMed ID: 25810375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hedgehog signal inhibitor forskolin suppresses cell proliferation and tumor growth of human rhabdomyosarcoma xenograft.
    Yamanaka H; Oue T; Uehara S; Fukuzawa M
    J Pediatr Surg; 2011 Feb; 46(2):320-5. PubMed ID: 21292081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Delivery of an Activatable Fluorescent Probe for the Detection of Furin Activity in Living Cells.
    Zhao X; Lv G; Peng Y; Liu Q; Li X; Wang S; Li K; Qiu L; Lin J
    Chembiochem; 2018 May; 19(10):1060-1065. PubMed ID: 29465834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic overexpression of the proprotein convertase furin enhances skin tumor growth.
    Fu J; Bassi DE; Zhang J; Li T; Nicolas E; Klein-Szanto AJ
    Neoplasia; 2012 Apr; 14(4):271-82. PubMed ID: 22577343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compartment-Specific Biosensors Reveal a Complementary Subcellular Distribution of Bioactive Furin and PC7.
    Ginefra P; Filippi BGH; Donovan P; Bessonnard S; Constam DB
    Cell Rep; 2018 Feb; 22(8):2176-2189. PubMed ID: 29466742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
    Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
    Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder.
    Kim W; Zekas E; Lodge R; Susan-Resiga D; Marcinkiewicz E; Essalmani R; Mihara K; Ramachandran R; Asahchop E; Gelman B; Cohen ÉA; Power C; Hollenberg MD; Seidah NG
    Mol Cell Biol; 2015 Nov; 35(21):3684-700. PubMed ID: 26283733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The proprotein convertase furin colocalizes with caveolin-1 in the Golgi apparatus and endosomes of hepatocytes.
    Mayer G; Boileau G; Bendayan M
    Cell Tissue Res; 2004 Apr; 316(1):55-63. PubMed ID: 14986103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage.
    Bergeron E; Basak A; Decroly E; Seidah NG
    Biochem J; 2003 Jul; 373(Pt 2):475-84. PubMed ID: 12691605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of the proprotein convertase furin by affinity chromatography based on PC-specific inhibitors.
    Kuester M; Becker GL; Hardes K; Lindberg I; Steinmetzer T; Than ME
    Biol Chem; 2011 Nov; 392(11):973-81. PubMed ID: 21875402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.
    Regenbogen S; Stagno MJ; Schleicher S; Schilbach K; Bösmüller H; Fuchs J; Schmid E; Seitz G
    Int J Oncol; 2020 Jul; 57(1):289-300. PubMed ID: 32377699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Furin and proprotein convertase 7 (PC7)/lymphoma PC endogenously expressed in rat liver can be resolved into distinct post-Golgi compartments.
    Wouters S; Leruth M; Decroly E; Vandenbranden M; Creemers JW; van de Loo JW; Ruysschaert JM; Courtoy PJ
    Biochem J; 1998 Dec; 336 ( Pt 2)(Pt 2):311-6. PubMed ID: 9820806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
    Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
    Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.
    Małuch I; Levesque C; Kwiatkowska A; Couture F; Ly K; Desjardins R; Neugebauer WA; Prahl A; Day R
    J Med Chem; 2017 Apr; 60(7):2732-2744. PubMed ID: 28287731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.